AkzoNobel annouces the sale of its biomaterials technology to Ashland Inc.
AkzoNobel announces the sale of its biomaterials technology to Ashland Inc. The transaction is expected to be complete in the third quarter of this year.
The business is in its early phase of commercialization and the divestment of the biomaterials technology follows a strategic review of the business' fit within AkzoNobel's portfolio, according to the company. The transaction enables AkzoNobel to focus on its core technology platforms - specialty surfactants and polymers.
The biomaterials activities are focused on plant-based chemistry, which is used to develop products for various applications, such as high performance beauty technologies.
Many facilities handle dangerous processes and products on a daily basis. Keeping everything under control demands well-trained people working with the best equipment.
Enhance the training experience and increase retention by training hands-on in Emerson's Interactive Plant Environment. Build skills here so you have them where and when it matters...
See how Rosemount™ 625IR Fixed Gas Detector helps keep workers safe with ultra-fast response times to detect hydrocarbon gases before they can create dangerous situations.
